Early Vascular Adjustments During Hypertensive Pregnancy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 368 participants.

Also called NCT02531490

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 368 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02531490
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02531490. Randomized; no masking; primary purpose prevention. Start 2015-01-01 (actual); primary completion 2023-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Vascular Adjustments During Hypertensive Pregnancy
Acronym
EVA
Condition
Hypertension, Pregnancy-Induced
Condition
Pre-Eclampsia
Intervention (Drug)
Labetalol
Intervention (Drug)
Nifedipine
Intervention (Drug)
Methyldopa
Lead sponsor
Maastricht University Medical Center (class: other)

Record details

Record id
cardio:ct-nct02531490
Content hash
240faf16fc9c17b9724f2a1d5f74814c2a4a2193940f31a385dd389a46827dab